These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2862443)

  • 1. Evaluating HTLV-III antibody tests.
    Prentice RL; Collins RJ; Wilson RJ
    Lancet; 1985 Aug; 2(8449):274-5. PubMed ID: 2862443
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of HTLV-III and changes in immunity in heroin addicts].
    Arribas JM; Asensi V; Pérez R; Navia-Osorio JM; Esteban J; Cartón JA; Fernández A
    Rev Clin Esp; 1985 Jul; 177(3):123-6. PubMed ID: 2997861
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune functions in HTLV-III antibody positive homosexual men without clinical AIDS.
    Krohn K; Ranki A; Antonen J; Valle SL; Suni J; Vaheri A; Saxinger C; Gallo RC
    Lancet; 1984 Sep; 2(8405):746-7. PubMed ID: 6148491
    [No Abstract]   [Full Text] [Related]  

  • 4. Roles of HTLV-I p19 and natural antibody to HTLV-I in host immune responses.
    Aoki T; Hamada C; Ohno S; Miyakoshi H; Kaneko Y; Robert-Guroff M; Ting RC; Gallo RC
    Haematol Blood Transfus; 1985; 29():342-4. PubMed ID: 2993130
    [No Abstract]   [Full Text] [Related]  

  • 5. False positive anti-HTLV III serology.
    Neale TJ; Dagger J; Fong R; Humble M; Meech P; Hatfield PJ; Morrison RB
    N Z Med J; 1985 Oct; 98(789):914. PubMed ID: 2997679
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of antibody to HTLV-III by commercial kits.
    O'Shaughnessy MV; Benning BJ; Neumann PW
    CMAJ; 1985 Sep; 133(6):551, 555. PubMed ID: 2992733
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute HTLV III infection.
    Romeril KR
    N Z Med J; 1985 May; 98(779):401. PubMed ID: 2986065
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS: the significance of anti-HTLV-III antibodies.
    Robinson PA; Brough J; Haddy L; Belshe RB; Khakoo R; Stevenson MM
    W V Med J; 1985 Sep; 81(9):194-7. PubMed ID: 2998098
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of anti-LAV/HTLV-III in prostitutes in Seville].
    Pineda JA; Leal M; García de Pesquera F; Sánchez-Quijano A; Rivera F; Lissen E
    Med Clin (Barc); 1986 Mar; 86(12):498-500. PubMed ID: 3012223
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantitation of and neutralizing antibodies to AIDS-retroviruses; a novel system using HTLV-I carrying MT-4 cells].
    Harada S; Yamamoto N
    Tanpakushitsu Kakusan Koso; 1985 Dec; 30(13):1394-407. PubMed ID: 3003812
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-Hodgkin's lymphoma and HTLV-1 antibodies in a gorilla.
    Lee RV; Prowten AW; Satchidanand SK; Srivastava BI
    N Engl J Med; 1985 Jan; 312(2):118-9. PubMed ID: 2981109
    [No Abstract]   [Full Text] [Related]  

  • 13. [Persistent polyadenopathy syndrome and immunity in parenteral drug addicts infected with HTLV-III].
    Asensi V; Cartón JA; Navia-Osorio JM; Meana A; Fernández León A; Cárcaba V; Sala P; Arribas JM
    Rev Clin Esp; 1986 Mar; 178(5):210-4. PubMed ID: 3012667
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
    Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological changes in HTLV-III infections and AIDS].
    Krohn K; Antonen J
    Duodecim; 1986; 102(7):413-22. PubMed ID: 2424708
    [No Abstract]   [Full Text] [Related]  

  • 16. [Morphological examination of lymphocytes from human T-cell leukemia virus (HTLV) carriers].
    Amagasaki T; Momita S; Suzuyama J; Yamada Y; Ikeda S; Kinoshita K; Ichimaru M
    Rinsho Ketsueki; 1985 Sep; 26(9):1430-5. PubMed ID: 3003419
    [No Abstract]   [Full Text] [Related]  

  • 17. Infection of T4 lymphocytes by HTLV-III does not require expression of the OKT4 epitope.
    Hoxie JA; Flaherty LE; Haggarty BS; Rackowski JL
    J Immunol; 1986 Jan; 136(2):361-3. PubMed ID: 2416802
    [No Abstract]   [Full Text] [Related]  

  • 18. Diversity of clinical spectrum of HTLV-III infection.
    Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
    Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies.
    Lyons SF; McGillivray GM; Coppin AP; Schoub BD
    S Afr Med J; 1985 Oct; 68(8):575-6. PubMed ID: 2996159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human T-cell leukemia (lymphoma) virus (HTLV-I) antibodies in Danish patients with cutaneous T-cell lymphoma].
    Wantzin GL
    Hautarzt; 1986 May; 37(5):263-5. PubMed ID: 3015842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.